Sandoz Inc, a division of Novartis (NYSE:NVS), President of US and Head of North America Carol Lynch sat down with Proactive Investors at BIO CEO in New York. Carol spoke about hurdles the US market is facing in the biosimilars space. She leads the Sandoz US commercial and country organization, responsible for over 35% of the coompany's global revenue, and oversees commercial operations in Canada.
Sandoz 'pioneering' in the biosimilars space to help reduce the increasing cost of care
Quick facts: Novartis AG (ADR)
Price: 90.94 USD
Market Cap: $208.16 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...FOR OUR FULL DISCLAIMER CLICK HERE